Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease (DKD) ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on aTyr Pharma (ATYR – Research Report) today and set a price target of $20.00. The company’s shares closed yesterday at $3.99.

Zydus Lifesciences is planning to acquire European medical technology company Amplitude Surgical ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex ...

The exports of the Indian pharmaceutical sector have witnessed a solid performance in the January to March quarter (Q4) of the 2024-25 fiscal year (FY25), with Contract Development and Manufacturing ...

March 11 (Reuters) - India's Zydus Lifesciences (ZYDU.NS), opens new tab said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical (AMPLI.PA), opens new tab for 256.8 million ...

Zydus Lifesciences received approval from the USFDA to market Ketoconazole Shampoo, an antifungal medication, in the US. This approval is for a generic version targeting dandruff and various fungal ...

Pointing out that 40,000 diseases in the world have no cure and presents an opportunity for new drug discoveries, Pankaj Patel, chairman of Zydus Lifesciences Ltd on Monday said Government on ...

Zydus Lifesciences received the final approval from the United States Food and Drug Administration to manufacture Dasatinib Tablets. Galaxy Surfactants entered into a strategic collaboration via its ...

Ahmedabad: Global lifesciences company, Zydus Lifesciences Limited, has announced the development of a combination vaccine against shigellosis and typhoid. Zydus will carry out early-stage development ...

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company, with support from the Gates Foundation, will carry out ...